Solute carrier family 8 member B1 (SLC8B1) (SLC8B1)

The Mitochondrial Na+/Ca2+ exchanger, primarily identified as Solute carrier family 8 member B1 (SLC8B1 or NCLX), is a critical transporter located in the inner mitochondrial membrane (UniProt Q9UPR5). Its primary function is to extrude calcium from the mitochondrial matrix in exchange for sodium or lithium, thereby playing a central role in maintaining mitochondrial calcium homeostasis (PubMed: 20133783). By regulating mitochondrial calcium levels, NCLX influences ATP production, reactive oxygen species generation, and the initiation of apoptosis. Dysregulation of NCLX has been linked to various pathologies, including neurodegenerative diseases like Parkinson's and Alzheimer's, where impaired calcium handling contributes to neuronal death (PubMed: 30858115). In the cardiovascular system, NCLX activity is vital for proper excitation-contraction coupling and protection against heart failure (PubMed: 28559418). In the context of metabolic health, NCLX is involved in glucose-stimulated insulin secretion in pancreatic beta cells (PubMed: 24510474). Pharmacological modulation of NCLX, primarily through inhibitors like CGP-37157, is being explored to manage conditions characterized by calcium signaling imbalances, though the risk of mitochondrial calcium overload leading to the opening of the mitochondrial permeability transition pore remains a significant therapeutic challenge.

Other names

NCLXMitochondrial sodium/calcium exchangerSodium/calcium/lithium exchangerSLC24A6SCMX

Inhibition of the exchanger prevents the efflux of calcium from the mitochondrial matrix to the cytosol, thereby modulating mitochondrial calcium concentrations and downstream signaling pathways.